References
- Townley WA, Baker R, Sheppard N, et al. Dupuytren’s contracture unfolded. BMJ 2006;332:397-400
- Swartz WM, Lalonde DH. MOC-PSSM CME article: Dupuytren’s disease. Plast Reconstr Surg 2008;121(Suppl):1-10
- Gudmundsson KG, Arngrimsson R, Jónsson T. Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren’s disease. Scand J Rheumatol 2001;30:31-4
- Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren’s contracture. J Hand Surg Am 2007;32:767-74
- DiBenedetti DB, Nguyen D, Zografos L, et al. Prevalence, incidence, and treatments of Dupuytren’s disease in the United States: results from a population-based study. Hand (N Y) 2011;6:149-58
- Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren’s disease incidence and prevalence rates in relation to etiology. Hand (N Y) 2009;4:256-69
- Noble J, Heathcote JG, Cohen H. Diabetes mellitus in the aetiology of Dupuytren’s disease. J Bone Joint Surg Br 1984;66:322-5
- Critchley EM, Vakil SD, Hayward HW, et al. Dupuytren’s disease in epilepsy: result of prolonged administration of anticonvulsants. J Neurol Neurosurg Psychiatry 1976;39:498-503
- Burge P, Hoy G, Regan P, et al. Smoking, alcohol and the risk of Dupuytren’s contracture. J Bone Joint Surg 1997;79:206-10
- Cakir M, Samanci N, Balci N, et al. Musculoskeletal manifestations in patients with thyroid disease. Clin Endocrinol (Oxf) 2003;59:162-7
- Smith SP, Devaraj VS, Bunker TD. The association between frozen shoulder and Dupuytren’s disease. J Shoulder Elbow Surg 2001;10:149-51
- Sandersson PL, Morris MA, Stanley JK, et al. Lipids and Dupuytren’s disease. J Bone Joint Surg 1992;74:923-7
- Bayat A, McGrouther DA. Management of Dupuytren’s disease–clear advice for an elusive condition. Ann R Coll Surg Engl 2006;88:3-8
- Ketchum LD, Donahue TK. The injection of nodules of Dupuytren’s disease with triamcinolone acetonide. J Hand Surg Am 2000;25:1157
- Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am 2011;36:936-42
- U.S. Food and Drug Administration. FDA Approves Xiaflex for Debilitating Hand Condition. FDA News Release. Washington, DC: U.S. Food and Drug Administration, 2010. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm199736.htm. Accessed June 29, 2011
- Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med 2009;361:968-79
- Maravic M, Landais P. Dupuytren’s disease in France–1831 to 2001–from description to economic burden. J Hand Surg Br 2005;30:484-7
- Gerber RA, Perry R, Thompson R, et al. Dupuytren’s contracture: a retrospective database analysis to assess clinical management and costs in England. BMC Musculoskelet Disord 2011;12:73
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
- Romano PS, Roos LL, Jollis J. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 1993;46:1075-9